Novavax Says Phase Three Of COVID-19 Vaccine Trial Could Begin In US By End Of November
Novavax Says Phase Three Of COVID-19 Vaccine Trial Could Begin In US By End Of November

Maryland-based Novavax gave an update Tuesday on Phase Three of its COVID-19 vaccine trial.